Hongjie Chen Selected Research

Hongjie Chen Research Topics

Disease

10	Neoplasms (Cancer) 07/2022 - 01/2011
6	Chronic Hepatitis B 01/2022 - 07/2019
6	Glioma (Gliomas) 07/2021 - 01/2011
3	Infections 07/2022 - 01/2021
3	Inflammation (Inflammations) 02/2022 - 01/2013
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2021
2	Carcinogenesis 07/2022 - 10/2019
2	Osteoarthritis 06/2022 - 02/2022
2	COVID-19 04/2022 - 06/2021
2	Stroke (Strokes) 02/2022 - 01/2013
2	Diarrhea 01/2022 - 01/2022
2	Heart Failure 01/2022 - 11/2019
2	Hepatitis B 06/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 07/2018
2	Cataract (Cataracts) 10/2020 - 02/2013
2	Adenocarcinoma of Lung 01/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2018
2	Pneumonia (Pneumonitis) 01/2017 - 10/2014
2	Vascular System Injuries 05/2011 - 05/2009
1	Reinfection 07/2022
1	Carcinoma (Carcinomatosis) 07/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022
1	Rheumatoid Arthritis 02/2022
1	Hypertrophy 01/2022
1	Lipodystrophy 11/2021
1	Kidney Neoplasms (Kidney Cancer) 07/2021
1	Melanoma (Melanoma, Malignant) 07/2021
1	Hypoglycemia (Reactive Hypoglycemia) 03/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Brain Diseases (Brain Disorder) 11/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Multiple Myeloma 01/2020
1	Hemorrhagic Stroke 11/2019
1	Endocarditis 11/2019
1	Renal Insufficiency (Renal Failure) 11/2019

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 07/2022 - 03/2009
4	WastewaterIBA 07/2022 - 01/2017
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 04/2020
3	VaccinesIBA 07/2022 - 01/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2018
3	Peptides (Polypeptides)IBA 01/2022 - 01/2011
3	Estrogen ReceptorsIBA 07/2021 - 11/2019
3	AntigensIBA 06/2021 - 01/2011
3	Antiviral Agents (Antivirals)IBA 06/2021 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2020 - 02/2013
2	Monoclonal AntibodiesIBA 01/2022 - 01/2018
2	InterferonsIBA 06/2021 - 04/2020
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 10/2019
2	EnzymesIBA 01/2021 - 02/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2017
2	Hepatitis B e AntigensIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
2	Selenious Acid (Selenite)IBA 10/2020 - 02/2013
2	Sodium SeleniteIBA 10/2020 - 02/2013
2	Pharmaceutical PreparationsIBA 11/2019 - 01/2018
2	CytokinesIBA 01/2017 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011 - 05/2009
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2011 - 05/2009
1	DecorinIBA 07/2022
1	nangibotideIBA 06/2022
1	lipoarabinomannan (LAM)IBA 02/2022
1	toddalolactoneIBA 02/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	CholesterolIBA 11/2021
1	Complement System Proteins (Complement)IBA 06/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2021
1	serglycinIBA 01/2021
1	Colchicine FDA LinkGeneric 01/2021
1	nasIBA 01/2021
1	TubulinIBA 01/2021
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	glochidiolIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Cholinesterases (Cholinesterase)IBA 01/2021
1	TriterpenesIBA 01/2021
1	Lysine (L-Lysine)FDA Link 11/2020
1	Superoxide DismutaseIBA 10/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2020
1	Glutathione PeroxidaseIBA 10/2020
1	Hematoxylin (Haematoxylon)IBA 10/2020
1	Malondialdehyde (Propanedial)IBA 10/2020
1	Thioredoxin-Disulfide ReductaseIBA 10/2020
1	methionine sulfoxide reductaseIBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Ubiquitin-Conjugating EnzymesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2019

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2012
2	Immunotherapy 01/2022 - 01/2011
1	Length of Stay 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Retreatment 01/2021
1	Withholding Treatment 04/2020